Life Sciences Firm Working on Diabetes Cure
August 31, 2010
An Indiana company believes it is developing a potential cure for Type I diabetes. Ikotech, currently located at the Purdue Research Park of Southeast Indiana, utilizes technology used in the diagnostics of other diseases to turn pancreatic donations into viable tissues for patients. President David Kennedy talks to Inside INdiana Business Host Gerry Dick about the company.
Ikotech is a spinoff of Greenville-based Techshot Inc. and relocated from Ohio to Indiana to partner with Purdue University and its life sciences researchers.
May 29, 2015
This RFA requests submissions of project applications for research use of human bio-specimen with longitudinal electronic medical record data. The due date for this Request for Applications is Friday, October 2, 2015. All Purdue full-time faculty members on the West Lafayette campus, regardless of tenure status, are eligible to apply. Samples will be provided free of charge to the qualified awardee(s).Read Full Story
May 15, 2015
The Molecular Therapeutics Program (MTP) released the IDDA 2015 RFA on May 8, 2015. Please see the link for guidelines. If you have any questions, please direct them to Padma Portonovo, who is the Program Manager for the MTP at email@example.com.Read Full Story
May 8, 2015
Purdue University and Indiana University Health Arnett in Lafayette have announced a three-year collaboration agreement to promote human clinical research efforts between the two groups.Read Full Story